Aspen raises a $141M IPO in pursuit of a cell therapy for Parkinson’s
BioPharma DiveGwendolyn WuOctober 30, 2026
The San Diego biotechnology startup is one of several firms working on a cutting-edge technique with the potential to slow or even halt the neurodegenerative condition.